Carolyn Rebeiro from Mining.com.au sits down with ABx Group Limited (ASX:ABX) Managing Director and CEO Dr Mark Cooksey and Corporate Connect Senior Equities Analyst Richard Close for an in-depth look at the company and its value proposition.
05 Feb 2024 - Chariot Corporation (ASX:CC9) Managing Director Shanthar Pathmanathan and Geological Consultant Dr Edward Max Baker discuss the significance of the company's latest drill results.
2 Dec 2019 - DomaCom Limited (ASX:DCL) CEO Arthur Naoumidis talks about a year of significant progress with regulators, the company's capital raising to accelerate marketing and FUM and the tailwinds making fractional investment attractive.
28 Aug 2019 - Ingenia Communities Group Limited (ASX:INA) CFO, Scott Noble discusses the company's FY19 results, its portfolio and the demand for seniors' accommodation.
23 Sep 2021 - AD1 Holdings Limited (ASX:AD1) CEO and Managing Director Brendan Kavenagh provides an update on the company's suite of software as a service businesses, FY21 results and outlook.
08 Nov 2023 - Hatch Managing Director of Australia and Asia Jan Kwak discusses key commodities, geographical opportunities, innovation, applying the circular economic model to mining, and the process of producing feasibility studies.
28 Feb 2024 - Graeme Sloan - Managing Director - Kali Metals (ASX:KM1) is a portfolio of assets that represents one of the largest and most prospective exploration packages across Australia’s world leading hard-rock lithium fields.
25 Feb 2020 - Noxopharm Limited (ASX:NOX) Chief Medical Officer, Dr Gisela Mautner, talks about results from the company's LuPIN trial in prostate cancer, evaluating its lead product candidate, Veyonda, in combination with 177Lu-PSMA-617, a radiopharmaceutical therapy, in 56 patients with late-stage prostate cancer.
30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
16 Dec 2019 - Sienna Cancer Diagnostics Limited (ASX:SDX) Managing Director and CEO Carl Stubbings talks about the company's capital raising and co-development of tests using its SIEN-NET liquid biopsies platform technology.